Retaining competitive edge through technology investment, rather than quality improvement, appears to be a powerful driver in the reconfiguration of surgical cancer centres in England.
The London School of Hygiene & Tropical Medicine is to lead a major new clinical trial in Southern and East Africa which aims to tackle the high number of deaths caused by HIV
